• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-20
Device Problems Particulates (1451); Device Operates Differently Than Expected (2913)
Patient Problems Fall (1848); Muscle Weakness (1967); Pain (1994); Complaint, Ill-Defined (2331); Ambulation Difficulties (2544)
Event Date 07/01/2017
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from patient who reported that the pump was currently delivering clonidine (1500 mcg/ml at 270. 5 mcg/day) and dilaudid (20. 0 mg/ml at 3. 602 mg/day). The patient was calling for mri compatibility guidelines as she was having problems with her back. She had neuropathy in both legs and weakness in her left leg. The doctor recommended an mri of the lower and thoracic part of her back under sedation. In a week¿s timeframe, she had fallen 5 times. She couldn¿t walk and was in a wheelchair. The patient had leg pain from the left side, lower back into hip area and down the left leg; the pain radiated down the left leg. The event date was unknown by the patient. No further complications have been reported as a result of this event.
 
Manufacturer Narrative
Refers to the main device. Other components include: product id 8731sc, serial# (b)(4), implanted: (b)(6) 2009, product type catheter.
 
Event Description
Information was received from a patient who was receiving 1500. 0 mcg/ml of clonidine at 581. 9 mcg/day and 20. 0 mg/ml of dilaudid at 7. 758 mg/day via an implantable pump for non-malignant pain. On (b)(6) 2017, it was reported that the patient had experienced falls and the patient's catheter was believed to be an issue. According to the patient, they had taken "some falls" approximately 2 months prior to the date of the report. The patient had "5 falls in a week", which left them unable to walk. The patient noted that they have a pre-existing condition of neuropathy which affects one of their legs. However, the falls were on the patient's "good leg". The patient's healthcare provider (hcp) is reportedly concerned that the catheter may be an issue and might be causing the patient to be unable to walk. According to the patient, the hcp informed them that it was not uncommon for dilaudid to crystallize at the catheter tip and cause problems. The hcp reportedly wanted to do an mri to rule-out potential catheter issues or the patient's pre-existing arthritic spurs. The patient is unable to lie down for the mri and an mri with sedation was requested. 2 mris were ordered, one with contrast and one without, as a previously performed ct scan was unable to obtain the image needed for assessment. It was later reported that the patient had a pump replacement due to normal battery depletion, but that the catheter was not replaced. The patient confirmed that their hcp suspected crystallization of the dilaudid forming. An mri was being performed that was due "partially" to the pump. The patient later reported their drugs as "clonidine: concentration: 1500 mg/ml - dose : 82. 5 mg/day and 8. 51 mcg/ml, dilaudid: concentration 20. 0 mg/ml - dose : 1. 099 mg/day and "7. 758 mcg/ml ". Additional information was received on (b)(6) 2017. The patient again reported that they could not walk and did not know if they could make it to their hcp after the "scan for the pump check". The patient was inquiring about adjustments prior to mri no further complications were reported the patient¿s medical history included a pre-existing condition of neuropathy, a pre-existing condition of arthritic spurs, 2 laminectomies and a spinal fusion occurring 40 years prior. These were reported as being unrelated to the pump.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNCHROMED II
Type of DevicePUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6918714
MDR Text Key103088713
Report Number3004209178-2017-20752
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation
Type of Report Initial,Followup
Report Date 01/08/2018
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received10/05/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date09/28/2016
Device Model Number8637-20
Device Catalogue Number8637-20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received01/05/2018
Was Device Evaluated by Manufacturer? No Answer Provided
Date Device Manufactured04/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-